Log in to save to my catalogue

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infa...

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infa...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c750905dbd84b2b9acf8d38c706c0ae

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock

About this item

Full title

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock

Publisher

Public Library of Science (PLoS)

Journal title

PloS one, 2022-01, Vol.17 (8), p.e0272279

Language

English

Formats

Publication information

Publisher

Public Library of Science (PLoS)

More information

Scope and Contents

Contents

BackgroundVasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in AMICS patients stratified according to the Society of Cardiovascular Angiography and Intervent...

Alternative Titles

Full title

Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5c750905dbd84b2b9acf8d38c706c0ae

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5c750905dbd84b2b9acf8d38c706c0ae

Other Identifiers

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0272279

How to access this item